OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis
暂无分享,去创建一个
P. Lollini | M. Colombo | P. Nanni | C. De Giovanni | A. Palladini | G. Nicoletti | M. Ianzano | L. Landuzzi | I. Arioli | Alessia Burocchi | Marianna L. Ianzano